Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 35 | 2023 | 3047 | 5.590 |
Why?
|
| Walking | 13 | 2020 | 1180 | 2.840 |
Why?
|
| Tai Ji | 6 | 2021 | 285 | 1.830 |
Why?
|
| Monitoring, Ambulatory | 7 | 2015 | 355 | 1.770 |
Why?
|
| Actigraphy | 6 | 2020 | 488 | 1.640 |
Why?
|
| Exercise Therapy | 7 | 2019 | 904 | 1.630 |
Why?
|
| Exercise Tolerance | 6 | 2022 | 768 | 1.330 |
Why?
|
| Self Efficacy | 7 | 2020 | 615 | 1.310 |
Why?
|
| Exercise | 11 | 2023 | 5615 | 1.120 |
Why?
|
| Veterans | 7 | 2022 | 2519 | 1.050 |
Why?
|
| Dyspnea | 11 | 2021 | 1303 | 0.940 |
Why?
|
| Quality of Life | 15 | 2023 | 12802 | 0.790 |
Why?
|
| Forced Expiratory Volume | 12 | 2021 | 1745 | 0.780 |
Why?
|
| Motor Activity | 4 | 2015 | 2715 | 0.770 |
Why?
|
| Internet | 6 | 2020 | 3056 | 0.700 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2019 | 367 | 0.610 |
Why?
|
| Interleukin-6 | 3 | 2018 | 3203 | 0.490 |
Why?
|
| Soot | 3 | 2018 | 232 | 0.430 |
Why?
|
| C-Reactive Protein | 3 | 2018 | 3778 | 0.430 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 247 | 0.390 |
Why?
|
| Self Care | 2 | 2015 | 786 | 0.390 |
Why?
|
| Activities of Daily Living | 3 | 2018 | 2419 | 0.370 |
Why?
|
| Exercise Test | 2 | 2018 | 2073 | 0.350 |
Why?
|
| Pulmonary Emphysema | 5 | 2002 | 672 | 0.330 |
Why?
|
| Albuterol | 2 | 2001 | 208 | 0.330 |
Why?
|
| Aged | 31 | 2022 | 163288 | 0.330 |
Why?
|
| Clinical Protocols | 1 | 2014 | 1461 | 0.320 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3646 | 0.310 |
Why?
|
| DNA Methylation | 1 | 2021 | 4285 | 0.300 |
Why?
|
| Self Report | 1 | 2018 | 3553 | 0.290 |
Why?
|
| Physical Endurance | 1 | 2009 | 370 | 0.280 |
Why?
|
| Male | 40 | 2022 | 350115 | 0.270 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 1438 | 0.260 |
Why?
|
| Bronchodilator Agents | 3 | 2018 | 502 | 0.250 |
Why?
|
| Middle Aged | 27 | 2022 | 213390 | 0.250 |
Why?
|
| Vital Capacity | 4 | 2018 | 925 | 0.240 |
Why?
|
| Pneumonectomy | 5 | 2002 | 1094 | 0.220 |
Why?
|
| Aging | 1 | 2021 | 8664 | 0.210 |
Why?
|
| Female | 33 | 2022 | 380193 | 0.210 |
Why?
|
| Social Support | 3 | 2017 | 2118 | 0.210 |
Why?
|
| Dust | 1 | 2004 | 482 | 0.200 |
Why?
|
| Motivation | 3 | 2017 | 1971 | 0.200 |
Why?
|
| Humans | 45 | 2023 | 744366 | 0.200 |
Why?
|
| Air Pollution, Indoor | 2 | 2018 | 857 | 0.200 |
Why?
|
| Respiration Disorders | 1 | 2004 | 371 | 0.190 |
Why?
|
| Hospitalization | 3 | 2015 | 10259 | 0.190 |
Why?
|
| Disease Progression | 4 | 2020 | 13286 | 0.190 |
Why?
|
| Bronchoconstriction | 1 | 2000 | 143 | 0.180 |
Why?
|
| Sickness Impact Profile | 1 | 2001 | 302 | 0.180 |
Why?
|
| Hydroxyurea | 1 | 2001 | 289 | 0.170 |
Why?
|
| Asthma | 4 | 2004 | 6010 | 0.170 |
Why?
|
| Feasibility Studies | 3 | 2021 | 5077 | 0.170 |
Why?
|
| Seasons | 2 | 2017 | 1493 | 0.170 |
Why?
|
| Cohort Studies | 7 | 2021 | 40559 | 0.170 |
Why?
|
| Spirometry | 4 | 2015 | 865 | 0.160 |
Why?
|
| Bronchiolitis Obliterans | 1 | 1999 | 194 | 0.160 |
Why?
|
| Choice Behavior | 1 | 2004 | 802 | 0.160 |
Why?
|
| Time | 1 | 2019 | 542 | 0.150 |
Why?
|
| Respiration | 2 | 2021 | 1653 | 0.150 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 7658 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 9955 | 0.130 |
Why?
|
| Patient Education as Topic | 2 | 2015 | 2278 | 0.130 |
Why?
|
| Feedback, Psychological | 1 | 2015 | 97 | 0.130 |
Why?
|
| Depression | 2 | 2017 | 7759 | 0.120 |
Why?
|
| Breathing Exercises | 1 | 2014 | 53 | 0.120 |
Why?
|
| Occupational Exposure | 1 | 2004 | 1793 | 0.120 |
Why?
|
| Outpatients | 1 | 2021 | 1487 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2021 | 63107 | 0.110 |
Why?
|
| Body Composition | 1 | 2022 | 2402 | 0.110 |
Why?
|
| Self Concept | 1 | 2019 | 1025 | 0.110 |
Why?
|
| Aftercare | 1 | 2019 | 870 | 0.110 |
Why?
|
| Goals | 1 | 2018 | 707 | 0.110 |
Why?
|
| Perception | 1 | 2019 | 1198 | 0.100 |
Why?
|
| Respiratory Function Tests | 3 | 2001 | 1617 | 0.100 |
Why?
|
| Boston | 2 | 2017 | 9312 | 0.100 |
Why?
|
| Checklist | 1 | 2018 | 833 | 0.100 |
Why?
|
| Physical Fitness | 1 | 2015 | 732 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 1999 | 1155 | 0.090 |
Why?
|
| Particulate Matter | 2 | 2018 | 2529 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39052 | 0.080 |
Why?
|
| Language | 1 | 1998 | 1471 | 0.080 |
Why?
|
| Prognosis | 3 | 2014 | 29060 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25039 | 0.080 |
Why?
|
| Affect | 1 | 2015 | 1475 | 0.080 |
Why?
|
| Risk | 1 | 2020 | 9688 | 0.070 |
Why?
|
| Acceleration | 1 | 2008 | 181 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3084 | 0.070 |
Why?
|
| Respiratory Mechanics | 3 | 2006 | 686 | 0.070 |
Why?
|
| Inflammation | 2 | 2018 | 10637 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2021 | 77460 | 0.070 |
Why?
|
| Linear Models | 3 | 2008 | 5953 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 1998 | 3229 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2015 | 2684 | 0.060 |
Why?
|
| Reference Values | 1 | 2012 | 4982 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 57776 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2018 | 2816 | 0.060 |
Why?
|
| Emphysema | 1 | 2006 | 247 | 0.060 |
Why?
|
| Total Lung Capacity | 2 | 2002 | 143 | 0.060 |
Why?
|
| Airway Resistance | 2 | 2006 | 404 | 0.060 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2003 | 44 | 0.060 |
Why?
|
| United States | 3 | 2017 | 69872 | 0.060 |
Why?
|
| Pandemics | 1 | 2023 | 8385 | 0.050 |
Why?
|
| Emotions | 1 | 2014 | 2659 | 0.050 |
Why?
|
| Research Design | 2 | 2015 | 5984 | 0.050 |
Why?
|
| Oxygen | 1 | 2013 | 4189 | 0.050 |
Why?
|
| Adult | 9 | 2019 | 214052 | 0.050 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2001 | 74 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2021 | 135 | 0.050 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2000 | 77 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 19905 | 0.050 |
Why?
|
| Bronchial Provocation Tests | 1 | 2000 | 227 | 0.050 |
Why?
|
| Methacholine Chloride | 1 | 2000 | 233 | 0.050 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 1999 | 25 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2012 | 8319 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5321 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2004 | 3395 | 0.040 |
Why?
|
| Massachusetts | 2 | 2018 | 8662 | 0.040 |
Why?
|
| Work of Breathing | 1 | 1998 | 51 | 0.040 |
Why?
|
| Sensation | 1 | 2000 | 336 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 12721 | 0.040 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1998 | 139 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15297 | 0.040 |
Why?
|
| Cost Savings | 1 | 2022 | 925 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2014 | 53290 | 0.040 |
Why?
|
| Lung | 2 | 2006 | 9857 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1998 | 1105 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2018 | 707 | 0.030 |
Why?
|
| Health Status | 1 | 2009 | 4034 | 0.030 |
Why?
|
| Probability | 1 | 2001 | 2506 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2001 | 6366 | 0.030 |
Why?
|
| Particle Size | 1 | 2018 | 1642 | 0.030 |
Why?
|
| Health Surveys | 1 | 2004 | 4036 | 0.030 |
Why?
|
| Postoperative Period | 1 | 1999 | 1842 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 1998 | 664 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 1999 | 970 | 0.030 |
Why?
|
| Fear | 1 | 2021 | 1440 | 0.030 |
Why?
|
| Chest Pain | 1 | 1998 | 1114 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 4777 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 21748 | 0.020 |
Why?
|
| Logistic Models | 1 | 2004 | 13409 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2004 | 9145 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2022 | 3208 | 0.020 |
Why?
|
| Patient Selection | 1 | 2001 | 4216 | 0.020 |
Why?
|
| Acute Disease | 1 | 1998 | 7147 | 0.020 |
Why?
|
| Air Pollution | 1 | 2018 | 2286 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15078 | 0.020 |
Why?
|
| Models, Biological | 1 | 2001 | 9584 | 0.020 |
Why?
|
| Elasticity | 1 | 2006 | 657 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2018 | 4232 | 0.010 |
Why?
|
| Residual Volume | 1 | 2002 | 41 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15535 | 0.010 |
Why?
|
| Respiratory Muscles | 1 | 2002 | 139 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 2002 | 378 | 0.010 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2001 | 67 | 0.010 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2001 | 116 | 0.010 |
Why?
|
| Thoracic Wall | 1 | 2002 | 203 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2001 | 379 | 0.010 |
Why?
|
| Pressure | 1 | 2002 | 1203 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2002 | 1235 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2001 | 2031 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2716 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 13991 | 0.010 |
Why?
|
| Algorithms | 2 | 2006 | 13882 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2001 | 2645 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2001 | 12244 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14723 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20130 | 0.000 |
Why?
|
| Adolescent | 1 | 2006 | 85779 | 0.000 |
Why?
|
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_